SGLT-2 Inhibitors: Fighting Cardiovascular Disease Mortality in Diabetes

J Coll Physicians Surg Pak. 2019 Feb;29(2):195. doi: 10.29271/jcpsp.2019.02.195.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Blood Glucose / drug effects
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / mortality*
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / mortality*
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Male
  • Middle Aged
  • Severity of Illness Index
  • Sodium-Glucose Transporter 2 Inhibitors / therapeutic use*
  • Survival Analysis
  • Treatment Outcome

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors